| Kelley E Price, LPC | |
|
1700 S Lamar Blvd, Act 271, Austin, TX 78704 | |
| (512) 445-7700 | |
| Not Available |
| Full Name | Kelley E Price |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1700 S Lamar Blvd, Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003568395 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 83940 (Texas) | Primary |
| Entity Name | Austin Travis County Mental Health And Mental Retardation Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750337259 PECOS PAC ID: 9133016306 Enrollment ID: O20040305000036 |
News Archive
Agios Pharmaceuticals, a biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced multiple presentations at the American Association for Cancer Research (AACR) 101st Annual Meeting that highlight cancer metabolism as an approach to identify new ways to treat cancer, opening the potential for a new class of cancer drugs targeting metabolic enzymes.
Xenomics, Inc. has announced the issuance of its first European patent "Methods for detection of nucleic acid sequences in urine", EP 1634966 A2 that covers use of its proprietary transrenal nucleic acid technology in the area of prenatal diagnostics and genetic testing.
Experts from around the country will join faculty experts from the University of Louisville's James Graham Brown Cancer Center, a part of KentuckyOne Health, to look at the latest evidence-based medicine in treating metastatic cancer of the central nervous system.
Daktari Diagnostics, in collaboration with Harvard University, the Medical University of South Carolina, and the University of Zambia in Lusaka, is thrilled to announce that it has been awarded a Small Business Innovation Research grant by the National Institute of Health for a point-of-care sickle cell diagnostic test.
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelley E Price, LPC 1430 Collier St, Austin, TX 78704-2911 Ph: (512) 472-4357 | Kelley E Price, LPC 1700 S Lamar Blvd, Act 271, Austin, TX 78704 Ph: (512) 445-7700 |
News Archive
Agios Pharmaceuticals, a biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced multiple presentations at the American Association for Cancer Research (AACR) 101st Annual Meeting that highlight cancer metabolism as an approach to identify new ways to treat cancer, opening the potential for a new class of cancer drugs targeting metabolic enzymes.
Xenomics, Inc. has announced the issuance of its first European patent "Methods for detection of nucleic acid sequences in urine", EP 1634966 A2 that covers use of its proprietary transrenal nucleic acid technology in the area of prenatal diagnostics and genetic testing.
Experts from around the country will join faculty experts from the University of Louisville's James Graham Brown Cancer Center, a part of KentuckyOne Health, to look at the latest evidence-based medicine in treating metastatic cancer of the central nervous system.
Daktari Diagnostics, in collaboration with Harvard University, the Medical University of South Carolina, and the University of Zambia in Lusaka, is thrilled to announce that it has been awarded a Small Business Innovation Research grant by the National Institute of Health for a point-of-care sickle cell diagnostic test.
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
› Verified 9 days ago
Mr. David A Miller, LPC, MED Counselor Medicare: Not Enrolled in Medicare Practice Location: 1001 West Ave Ste B, Austin, TX 78701 Phone: 512-608-2024 | |
Ms. Virginia Adams Bloom, MED, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1310 S 1st St Ste 200, Austin, TX 78704 Phone: 512-627-0390 Fax: 512-288-1909 | |
Trina K Bluford Ita, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 910 E Cesar Chavez St, Austin, TX 78702 Phone: 888-823-9194 Fax: 888-708-9413 | |
Laura Violeta Duenas-guerrero, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2525 Wallingwood Dr, Bldg. 8, Ste. 800, Austin, TX 78746 Phone: 512-348-8713 | |
Paula Nicholas Storrer, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2404 W 8th St, Austin, TX 78703 Phone: 512-925-2412 | |
Amanda Lorina Cartwright, LCSW, LCDC Counselor Medicare: Accepting Medicare Assignments Practice Location: 4005 Spicewood Springs Rd Ste B401, Austin, TX 78759 Phone: 512-807-0898 | |
Jessica Lynn Stewart, M.A., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5015 S Ih 35, Austin, TX 78744 Phone: 512-804-3202 |